Tickers

1. Composite Trajectory Verdict

For an upstream oil and gas producer, the cash flow statement carries the most weight because capital intensity and commodity-price volatility make operating cash generation the primary indicator of financial sustainability, though the income statement and balance sheet provide essential context on profitability and leverage.

Composite Trajectory: Mixed

Annual operating cash flow improved 31% to $313.2M in 2025 (10-K 2025, Consolidated Statements of Cash Flows), and Q2 2026 funds flow from operations rose 12% year-over-year to $60.3M (10-Q Q2 2026, MD&A Funds flow from operations reconciliation). However, annual net income swung to a $193.1M loss from a $3.2M profit (10-K 2025, Consolidated Statements of Operations), adjusted EBITDA fell 23% to $283.7M (10-K 2025, MD&A Financial Highlights), and free cash flow deteriorated to -$78.5M from -$23.2M (10-K 2025, MD&A Funds flow reconciliation). The balance sheet weakened: shareholders’ equity nearly halved to $228.7M (10-K 2025, Consolidated Balance Sheets), net debt-to-adjusted-EBITDA rose to ~2.2x from ~1.8x, and cash declined 20% to $82.9M. Q2 2026 showed a sharp earnings rebound ($24.9M net income vs -$12.7M) on higher Brent prices, but Q4 2025 net loss widened to -$141.1M from -$34.2M (10-K 2025, MD&A Net Income (Loss) and Funds Flow table). These opposing vectors — stronger operating cash flow but deteriorating profitability, equity, and free cash flow — yield a mixed trajectory.

2. Red Flags

• Ceiling test impairment of $136.3M recorded in 2025 across Canada and Colombia due to lower commodity prices and revised development plans (10-K 2025, MD&A Asset Impairment).
• Shareholders’ equity declined 45% year-over-year, from $413.6M to $228.7M, driven by the $193.1M net loss (10-K 2025, Consolidated Balance Sheets).
• Free cash flow (non-GAAP) worsened to -$78.5M in 2025 from -$23.2M in 2024, despite a 31% increase in operating cash flow (10-K 2025, MD&A Funds flow reconciliation).
• Large unrealized derivative swings: Q1 2026 recorded a $77.3M loss; Q2 2026 recorded a $45.9M gain (10-Q Q2 2026, MD&A EBITDA reconciliation).
• $150M prepayment agreement with Trafigura recorded as a current ($34.1M) and long-term ($115.9M) liability, with asset coverage and debt service covenants tied to 80% of Brent forward strip (10-K 2025, MD&A Prepayment agreements).
• Senior Notes exchange subsequent to year-end: $628.7M of 9.50% notes exchanged for $503.6M of 9.75% notes with a $125M cash payment, reducing principal but increasing coupon and extending maturity (10-K 2025, Subsequent Events).
• Colombian 1% excise tax effective through 2025 with potential refund undetermined (10-K 2025, MD&A Overview).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results deteriorated: revenue fell 4% to $596.7M (10-K 2025, Consolidated Statements of Operations), net income swung to a $193.1M loss from a $3.2M profit, adjusted EBITDA dropped 23% to $283.7M (10-K 2025, MD&A Financial Highlights), and operating netback fell 17% to $330.9M (10-K 2025, MD&A Financial Highlights). Production volumes rose 38% to 38,443 BOEPD, but realized price per boe dropped 30% to $43.41 (10-K 2025, Consolidated Results of Operations per boe). Quarterly trends diverge: Q2 2026 net income improved to $24.9M from a -$12.7M loss in Q2 2025, with revenue up 25% to $187.2M and adjusted EBITDA up 11% to $85.1M (10-Q Q2 2026, MD&A Financial Highlights). Conversely, Q4 2025 net loss widened to -$141.1M from -$34.2M in Q4 2024, adjusted EBITDA fell 31% to $52.5M, and funds flow from operations dropped 39% to $26.8M (10-K 2025, MD&A Net Income (Loss) and Funds Flow table). The combination of annual decline and opposing quarterly moves results in a mixed earnings trajectory.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow increased 31% to $313.2M in 2025 (10-K 2025, Consolidated Statements of Cash Flows), driven by higher sales volumes and favorable working capital changes ($141.9M inflow vs $16.1M in 2024). Investing outflows moderated to -$272.5M from -$352.5M (10-K 2025, Consolidated Statements of Cash Flows). However, financing activities swung to a -$59.8M outflow from a $156.9M inflow in 2024, reflecting debt repayments ($119.9M) and senior note repurchases ($17.0M) without offsetting issuance proceeds (10-K 2025, Consolidated Statements of Cash Flows). Free cash flow (non-GAAP) deteriorated to -$78.5M from -$23.2M (10-K 2025, MD&A Funds flow reconciliation). Cash and cash equivalents fell 20% to $82.9M (10-K 2025, Consolidated Balance Sheets). Quarterly cash flow statements for 2026 are not provided in the filings, limiting intra-year trend analysis. The annual improvement in operating cash flow is offset by worsening free cash flow and a sharp financing cash flow reversal, yielding a mixed cash trajectory.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets declined 4% to $1.586B at 2025 year-end from $1.655B (10-K 2025, Consolidated Balance Sheets). Cash dropped 20% to $82.9M from $103.4M. Current liabilities rose 10% to $355.7M from $322.4M, partly due to a $34.1M current portion of the Trafigura prepayment (10-K 2025, Consolidated Balance Sheets; MD&A Prepayment agreements). Long-term debt decreased modestly to $686.5M from $722.1M, but a $115.9M customer advance (long-term prepayment liability) appeared (10-K 2025, Consolidated Balance Sheets). Shareholders’ equity fell 45% to $228.7M from $413.6M, and the accumulated deficit deepened to -$1.053B from -$859.8M (10-K 2025, Consolidated Balance Sheets). Net debt (total debt less cash) increased to ~$625M from ~$644M? Actually total debt $707.7M less cash $82.9M = $624.8M vs 2024 total debt $746.9M less cash $103.4M = $643.5M, so net debt slightly decreased, but adjusted EBITDA fell more, raising net debt-to-adjusted-EBITDA to ~2.2x from ~1.8x. The sharp equity erosion and higher leverage ratio indicate a deteriorating balance sheet.

6. Data Gaps

• Quarterly GAAP cash flow statements for Q1 2026, Q2 2026, Q3 2025, and Q2 2025 (not included in provided 10-Q excerpts).
• Quarterly balance sheets for 2026 periods (not provided).
• Q1 2025 and Q3 2024 income statement and cash flow data for year-over-year quarterly comparisons (not provided).
• Full-year 2026 actual results (only first half 2026 data available via 10-Q Q2 2026).
• Detailed composition of "Other non-cash (gain) loss" and "Other gain (loss)" line items across periods for trend analysis.